- Home
- / ProQR Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ProQR Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.5
2024-10-29
Market Capitalization
$281.8 M
2024-10-29
Revenue
€15.9 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4M | 4.0M | 6.5M | 18.9M | 15.9M | |||
| Gross profit | 5.8M | 1.9M | 9.5M | 2.4M | 4.8M | 6.6M | 19.5M | 16.3M |
| Gross profit margin, % | 177.0% | 118.9% | 101.2% | 103.4% | 102.8% | |||
| Operating expense total | 41.1M | 57.3M | 49.5M | 57.3M | 67.0M | 38.9M | 47.3M | 57.1M |
| Depreciation and amortization | 992.0K | 2.1M | 2.4M | 2.3M | 2.5M | 2.5M | 2.8M | 2.7M |
| EBITDA | (35.3M) | (55.0M) | (40.3M) | (54.6M) | (62.2M) | (32.2M) | (27.7M) | (40.7M) |
| EBITDA margin, % | -4029.9% | -1540.8% | -494.1% | -146.6% | -256.1% | |||
| EBIT | (36.3M) | (57.0M) | (42.7M) | (56.9M) | (64.7M) | (34.7M) | (30.5M) | (43.4M) |
| EBIT margin, % | -4201.9% | -1603.3% | -532.7% | -161.2% | -273.1% | |||
| Interest income | 189.0K | 763.0K | 313.0K | 5.0K | 106.0K | 2.6M | 3.3M | 2.3M |
| Interest expense | 810.0K | 1.1M | 2.1M | 3.4M | 5.1M | 1.2M | 1.1M | 929.0K |
| Pre tax profit | (37.1M) | (56.6M) | (46.5M) | (61.6M) | (64.8M) | (27.8M) | (28.0M) | (42.2M) |
| Income tax expense | 1.0K | 132.0K | 124.0K | 117.0K | 96.0K | (78.0K) | (197.0K) | 19.0K |
| Net Income | (37.1M) | (56.7M) | (46.6M) | (61.7M) | (64.9M) | (27.7M) | (27.8M) | (42.2M) |